Merck Secures First Oral PCSK9 Inhibitor, Boosts Q1 2026 Earnings and Expands Oncology Pipeline
Merck’s latest triumph—an FDA nod for its first oral PCSK9 inhibitor—comes on the heels of a stronger‑than‑exp...
Read story →Tag: Citi
View all →
Max Healthcare Shares Surge 6% After Citi Keeps Buy Rating
Shares of Max Healthcare Institute Ltd. leapt 6.27% on Thursday, closing at ₹1,090.45 on the National Stock Exchange a...
Read story →